PriceTargets.com logo

Consort Medical plc (CSRT.L) - CSRT Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: GBX 0
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,010 As of 03/6/2020 12:59 AM ET
▲ +5 (0.50%)

This chart shows the closing price for CSRT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Consort Medical plc (CSRT.L) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CSRT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CSRT

Analyst Price Target is GBX 0
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Consort Medical plc (CSRT.L) in the last 3 months. The average price target is GBX 0, with a high forecast of GBX 0 and a low forecast of £100,000. The average price target represents a -100.00% upside from the last price of GBX 1,010.

This chart shows the closing price for CSRT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Consort Medical plc (CSRT.L). This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/24/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/21/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/19/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/17/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/16/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/10/2020Royal Bank of CanadaUpgradeSector Performer
1/10/2020Royal Bank of CanadaDowngradeUnderperformGBX 1,200 ➝ GBX 1,010
11/19/2019Royal Bank of CanadaBoost TargetOutperformGBX 1,060 ➝ GBX 1,200
11/18/2019Shore CapitalDowngradeHold
10/18/2019Shore CapitalUpgradeBuy
9/27/2019Shore CapitalUpgradeBuy
9/11/2019Shore CapitalDowngradeHold
7/15/2019Shore CapitalReiterated RatingBuy
6/13/2019Royal Bank of CanadaLower TargetOutperformGBX 1,320 ➝ GBX 1,130
6/13/2019Shore CapitalReiterated RatingBuy
6/6/2019Numis SecuritiesDowngradeHold
(Data available from 4/16/2019 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
10/19/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/18/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/18/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/17/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/16/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/17/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/16/2024

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
Consort Medical plc (CSRT.L) logo
Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.
Read More

Today's Range

Now: GBX 1,010
Low: 1,005
High: 1,010

50 Day Range

MA: GBX 1,010
Low: 1,010
High: 1,010

52 Week Range

Now: GBX 1,010
Low: 702
High: 1,075

Volume

768 shs

Average Volume

520,697 shs

Market Capitalization

£504.60 million

P/E Ratio

127.85

Dividend Yield

2.75%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Consort Medical plc (CSRT.L)?

The following Wall Street analysts have issued reports on Consort Medical plc (CSRT.L) in the last twelve months:
View the latest analyst ratings for CSRT.

What is the current price target for Consort Medical plc (CSRT.L)?

0 Wall Street analysts have set twelve-month price targets for Consort Medical plc (CSRT.L) in the last year. has the lowest price target set, forecasting a price of £100,000 for Consort Medical plc (CSRT.L) in the next year.
View the latest price targets for CSRT.

What is the current consensus analyst rating for Consort Medical plc (CSRT.L)?

Consort Medical plc (CSRT.L) currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for CSRT.

What other companies compete with Consort Medical plc (CSRT.L)?

Other companies that are similar to Consort Medical plc (CSRT.L) include Silence Therapeutics, Amryt Pharma, PureTech Health, Advanced Medical Solutions Group and Uniphar. Learn More about companies similar to Consort Medical plc (CSRT.L).

How do I contact Consort Medical plc (CSRT.L)'s investor relations team?

Consort Medical plc (CSRT.L)'s physical mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company's listed phone number is +44-1442-867920. The official website for Consort Medical plc (CSRT.L) is www.consortmedical.com. Learn More about contacing Consort Medical plc (CSRT.L) investor relations.